The market is crashing. We are playing defense by investing in recession-resistant REITs. I present three of my favorite "buy-the-dip" opportunities.
Economic uncertainty under the new President has led to mixed market reactions, with growth being hit the hardest and some value names suffering as well. The Nasdaq-100 is down ~8% YTD, and the S&P 500 is down ~4% YTD, reflecting muted growth expectations. Current market conditions favor high-quality, income-focused investments, particularly defensive value plays with attractive valuations.
We stayed out of Alexandra Real Estate as we believed the headwinds were too strong to overcome. The stock is lower since then and normally we aim for bargain hunting. We tell you why we are more bearish today than we were 3 months back.
Alexandria Real Estate has become a battleground stock. But it shouldn't be. This is a blue-chip REIT that's dealing with a temporary crisis. As its growth accelerates, I expect up to 50% upside as Alexandria reprices at a more reasonable valuation multiple.
These 2 unloved dividend growth powerhouses could deliver serious upside once Mr. Market wakes up. Both combine aggressive buybacks when their shares trade at deep discounts with consistently impressive dividend growth. Both also have fortress balance sheets and world-class business models.
The real estate sector is off to a strong start in 2025, outperforming the S&P 500 (^GSPC 0.64%) by about 6 percentage points through mid-March. However, not all real estate investment trusts (REITs) have outperformed, and there are some excellent buying opportunities for patient long-term investors.
Some REITs are truly exceptional. So much so that they could make sense for most investors. I present two such exceptional REITs.
The REIT recovery has stalled in recent months. But I think that it will soon resume. I present the powerful catalyst that could push REITs a lot higher.
Alexandria Real Estate Equities has solid fundamentals and financials despite market pessimism, making it an attractive long-term investment with a 5%+ dividend yield. ARE's strong performance includes a 6% growth year-over-year and impressive leasing activity, supported by a robust balance sheet and low leverage. The REIT's current valuation at a forward P/FFO multiple of 10.21x is a bargain, offering significant upside potential over the next 12–24 months.
Alexandria Real Estate Equities (ARE) reported earnings 30 days ago. What's next for the stock?
Alexandria Real Estate Equities (ARE) is deeply undervalued, trading at just 10x AFFO with a 5.52% dividend yield, offering a 50% upside over three years. ARE's unique life science real estate assets in key markets are critical for top biotech and pharmaceutical companies, ensuring strong demand and high-quality tenants. The company has a robust development pipeline, high leasing rates, and strong financials, with 77% of rental revenue from Megacampuses and 52% from investment-grade tenants.
Alexandria Real Estate has experienced a 50% drop in share price, but its high-quality life science assets and strong tenant base suggest this decline is unreasonable. There are risks due to a (current) oversupply in this sector, but a flight to quality should protect ARE going forward. With a well-covered dividend and prudent capital allocation, including buybacks, my conservative analysis warrants at least a $130 share price (+36%).